Skip to main content

and
  1. Article

    Open Access

    Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer

    ONC201 is a dopamine receptor D2 (DRD2) antagonist that inhibits tumor growth in preclinical models through ClpP activation to induce integrated stress response pathway and mitochondrial events related to inhi...

    Stuart R. Pierce, Ziwei Fang, Yajie Yin in Journal of Experimental & Clinical Cancer … (2021)